Beyaz Ferhat, Geraats Renée M, Verhoeven Roel L J, van der Heijden Erik H F M, Hermens Rosella P M G, Swillens Julie E M
Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, Netherlands
Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
BMJ Open Respir Res. 2025 Jul 21;12(1):e002734. doi: 10.1136/bmjresp-2024-002734.
Early-stage lung cancer mostly occurs asymptomatically and is found incidentally as peripheral pulmonary nodules on medical imaging. Cone beam CT-guided navigation bronchoscopy (CBCT-NB) is a novel and evidence-based minimally invasive procedure to obtain a tissue diagnosis from these pulmonary nodules. To clinically implement this innovation in practice, this study investigated barriers and facilitators to CBCT-NB implementation in a nationwide setting as observed in the Netherlands.
In-depth semistructured interviews and focus groups were conducted among healthcare professionals directly involved in the CBCT-NB implementation in hospitals nationwide. The updated Consolidated Framework for Implementation Research (CFIR) was used for creating the interview guide and structuring the analysis.
13 healthcare professionals spearheading implementation efforts across eight hospitals (three university, five non-university hospitals) were interviewed. A total of 52 facilitators and 38 barriers were identified throughout all CFIR domains. Important facilitators to CBCT-NB implementation were patient safety, reimbursement availability, future demand, intrinsic motivation of local implementation leaders and regional network collaborations and coordination on implementation. Main barriers included financial constraints, uncertainty about the availability of important resources, the need for new and complex skills acquisition and the anticipated time needed for the entire implementation process.
CBCT-NB is described as a highly valuable innovation within the field of diagnostic procedures for pulmonary nodules. Our findings reveal important barriers and facilitators to CBCT-NB implementation. Understanding these factors is crucial for developing and optimising implementation strategies to achieve successful implementation of innovative minimally invasive image-guided procedures like CBCT-NB in a nationwide setting.
早期肺癌大多无症状发生,在医学影像检查中偶然发现为肺部外周结节。锥形束CT引导下的导航支气管镜检查(CBCT-NB)是一种新型的、基于证据的微创方法,可从这些肺部结节获取组织诊断。为了在临床实践中实施这一创新技术,本研究调查了在荷兰全国范围内观察到的CBCT-NB实施的障碍和促进因素。
对全国范围内直接参与CBCT-NB实施的医院医护人员进行了深入的半结构化访谈和焦点小组讨论。采用更新后的实施研究综合框架(CFIR)创建访谈指南并构建分析框架。
对来自八家医院(三家大学医院、五家非大学医院)率先开展实施工作的13名医护人员进行了访谈。在CFIR的所有领域共确定了52个促进因素和38个障碍。CBCT-NB实施的重要促进因素包括患者安全、报销政策、未来需求、当地实施负责人的内在动力以及区域网络在实施方面的协作与协调。主要障碍包括资金限制、重要资源可用性的不确定性、获取新的复杂技能的需求以及整个实施过程预计所需的时间。
CBCT-NB被描述为肺部结节诊断程序领域一项极具价值的创新技术。我们的研究结果揭示了CBCT-NB实施的重要障碍和促进因素。了解这些因素对于制定和优化实施策略至关重要,以便在全国范围内成功实施像CBCT-NB这样的创新性微创影像引导程序。